Skip to main content
. 2018 Oct 29;2018(10):CD012661. doi: 10.1002/14651858.CD012661.pub2

NCT02838693.

Trial name or title Assessing progression to type‐2 diabetes (APT‐2D): a prospective cohort study expanded from BRITE‐SPOT (Bio‐bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes) (APT‐2D)
Starting date March 2016
Contact information Sue‐Anne Toh, MBBChir, MSc, MA; +65 67722195; mdcsates@nus.edu.sg
Notes Estimated study completion date: December 2021